Search for Clinical Trial Results
Human T-cell Leukemia Virus Type 1 - 25 Studies Found
| Status | Study |
| Recruiting |
Study Name: Influence of IL28B Genetic Variation on the Phenotype Infection of HTLV-1 Condition: HTLV-I Infections Date: 2012-12-14 |
| Recruiting |
Study Name: Trial to Assess Effect of Raltegravir on HTLV-1 Proviral Load Condition: Human T-cell Leukemia Virus Type 1 Infection Date: 2012-01-25 Interventions: Drug: Raltegravir Raltegravir 400 mg po bid |
| Recruiting |
Study Name: Raltegravir for HAM/TSP Condition: HTLV-I Infection Date: 2013-05-21 Interventions: Drug: Raltegravir |
| Recruiting |
Study Name: Hu Mik-Beta-1 to Treat HTLV-1-Associated Myelopathy/Tropical Spastic Paraparesis Condition: HTLV-1 Date: 2006-07-12 Interventions: Drug: Hu MiK-Beta-1 |
| Completed |
Study Name: Zidovudine Plus Lamivudine in HTLV-I-associated Myelopathy: a Randomised Trial Condition: HTLV-I-associated Myelopathy Date: 2006-01-04 Interventions: Drug: Zidovudine/lamivudine |
| Completed |
Study Name: Efficacy and Safety of Tamibarotene(AM80H) for HTLV-1 Associated Myelopathy/ Tropical Spastic Paraparesis (HAM/TSP) Condition: HTLV-I-Associated Myelopathy Date: 2011-04-25 Interventions: Drug: Tamibarotene Oral administration of tamibarotene 2 mg daily over a period of 12 weeks, then 4mg da |
| Enrolling by invitation |
Study Name: Urological Physical Therapy in HTLV-1 With Urinary Symptoms Condition:
Date: 2012-07-25 Interventions: Procedure: Urological physical therapy Individual patient attending with one hour duration beginning wit |
| Not yet recruiting |
Study Name: Effect of Raltegravir in Patients With Acute Tropical Spastic Paraparesis - Human T-Lymphotropic Virus 1 Infection Condition:
Date: 2015-11-16 Interventions: Drug: "Raltegravir" and "Zidovudine" Through measure of pro-viral load and clinical |
| Completed |
Study Name: Recombinant Human Interferon Beta-1a (Avonex) for the Treatment of Patients With HTLV-1-Associated Myelopathy (HAM) Condition:
|